Nyxoah is a medical device company focused on the development and commercialization of a hypoglossal nerve stimulation (HGNS) therapy.

Health Care

Medical Devices

Neuroscience

Nyxoah

Nyxoah's headquarters in Mont-saint-guibert, Belgium

Olivier Taelman

Patrick Tompkins

Ashlea Mittelstaedt

Maggie McGowan

Jeyakumar Subbaroyan

Dan Mans

John Landry

Loïc Moreau

Bruno Onkelinx

Scott Holstine

Inge Vanwittenbergh

An Moonen

Daniel Wildman

Jürgen Hambrecht

Robert Taub

Kevin Rakin

Pierre Gianello

Virginia Kirby

The Directors and Executives team at Nyxoah oversees strategic decision-making, leadership, and governance, ensuring the effective development and commercialization of hypoglossal nerve stimulation (HGNS) therapy. This team sets corporate objectives, aligns operational activities with company goals, and maintains regulatory and quality compliance, driving innovation and growth within the medical device industry.

Directors and Executives

The Clinical Research and Affairs Team at Nyxoah oversees the planning, execution, and monitoring of clinical trials for the company's hypoglossal nerve stimulation (HGNS) therapy. They ensure regulatory compliance, data integrity, and patient safety throughout the research process. The team also collaborates with field experts to provide technical support, manage trial sites, and facilitate the approval and commercialization of Nyxoah’s medical devices.

Clinical Research and Affairs Team

The Engineering Team at Nyxoah is responsible for the development, testing, and optimization of the company's hypoglossal nerve stimulation (HGNS) therapy devices. This includes mechanical engineering of implants, algorithm development for therapy enhancement, quality assurance, project management, and IT support for implementation. They work collaboratively to ensure the devices meet high standards of performance, safety, and reliability.

Engineering Team

The Leadership Team at Nyxoah is responsible for strategic decision-making and guiding the company's vision in the development and commercialization of hypoglossal nerve stimulation therapy. Comprising key executives across various functions, including technology, quality, medical affairs, finance, and marketing, the team ensures alignment in operations and fosters innovation to enhance patient outcomes and expand market access for their medical devices.

Leadership Team

The Human Resources & Training team at Nyxoah is responsible for managing employee relations, recruitment, and professional development across the company. They implement training programs to ensure that staff are proficient and well-informed about the company's hypoglossal nerve stimulation (HGNS) therapy. Additionally, they oversee the office operations to maintain an efficient and supportive work environment.

Human Resources & Training

The Finance Team at Nyxoah manages the company's financial health by overseeing activities such as budgeting, financial reporting, and internal control. They ensure compliance with financial regulations, provide strategic financial planning, and support the company's growth and commercialization efforts. Team members collaborate to maintain accurate financial records, consolidate accounts, and oversee all financial transactions.

Nyxoah

Org chart

Board & advisors

Teams

Directors and Executives

Clinical Research and Affairs Team

Engineering Team

Leadership Team

Human Resources & Training

Finance Team

Offices

Nyxoah

Org chart

Board & advisors

Teams

Directors and Executives

Clinical Research and Affairs Team

Engineering Team

Leadership Team

Human Resources & Training

Finance Team

Offices

Related companies